Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2017-11-03

What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2017-11-03 (fiscal Q3 2017): 38 published measures, 104 facts as tagged in accession 0001161697-17-000469.

This filing

Form
10-Q (quarterly report)
Filed
2017-11-03
Fiscal period
fiscal Q3 2017
Accession
0001161697-17-000469 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-308,591,310USD
At 2017-02-288,170,249USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-301,254,628USD
At 2017-02-281,494,202USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-307,336,682USD
At 2017-02-286,676,047USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-303,661,707USD
At 2017-02-283,313,265USD
At 2016-09-303,638,652USD
At 2016-02-294,201,949USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30265,754USD92
2017-03-01 to 2017-09-30626,587USD214
2016-07-01 to 2016-09-30-153,213USD92
2016-03-01 to 2016-09-30-359,095USD214

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-03-01 to 2017-09-30531,281USD214
2016-03-01 to 2016-09-30-212,676USD214

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-03-01 to 2017-09-30134,640USD214
2016-03-01 to 2016-09-30123,689USD214

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-03-01 to 2017-09-30-163,479USD214
2016-03-01 to 2016-09-30-230,044USD214

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-303,111,528USD
At 2017-02-282,484,941USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-07-01 to 2017-09-3037,898,357shares92
2017-03-01 to 2017-09-3037,856,074shares214
2016-07-01 to 2016-09-3037,779,427shares92
2016-03-01 to 2016-09-3037,885,432shares214

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-07-01 to 2017-09-3038,056,604shares92
2017-03-01 to 2017-09-3038,014,321shares214
2016-07-01 to 2016-09-3037,779,427shares92
2016-03-01 to 2016-09-3037,885,432shares214

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-07-01 to 2017-09-300.01USD/shares92
2017-03-01 to 2017-09-300.02USD/shares214
2016-03-01 to 2016-09-30-0.01USD/shares214

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-07-01 to 2017-09-300.01USD/shares92
2017-03-01 to 2017-09-300.02USD/shares214
2016-03-01 to 2016-09-30-0.01USD/shares214

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-07-01 to 2017-09-30137,404USD92
2017-03-01 to 2017-09-30323,956USD214
2016-07-01 to 2016-09-30-78,217USD92
2016-03-01 to 2016-09-30-183,819USD214

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-09-30902,075USD
At 2017-02-28932,092USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-03-01 to 2017-09-3053,407USD214
2016-03-01 to 2016-09-30126,006USD214

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-09-30392,378USD92
2017-03-01 to 2017-09-30884,360USD214
2016-07-01 to 2016-09-30-227,596USD92
2016-03-01 to 2016-09-30-552,487USD214

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-09-307,217,087USD
At 2017-02-286,779,724USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-09-301,154,207USD
At 2017-02-281,389,284USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-09-30362,878USD
At 2017-02-28772,428USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-09-30440,565USD
At 2017-02-28426,943USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-09-301,481,410USD
At 2017-02-281,502,030USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,986,280USD92
2017-03-01 to 2017-09-304,764,392USD214
2016-07-01 to 2016-09-302,260,540USD92
2016-03-01 to 2016-09-305,202,257USD214

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-09-301,586,568USD
At 2017-02-281,353,703USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-07-01 to 2017-09-302,378,658USD92
2017-03-01 to 2017-09-305,648,752USD214
2016-07-01 to 2016-09-302,032,944USD92
2016-03-01 to 2016-09-304,649,770USD214

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,893,911USD92
2017-03-01 to 2017-09-304,536,954USD214
2016-07-01 to 2016-09-302,114,407USD92
2016-03-01 to 2016-09-304,887,608USD214

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-07-01 to 2017-09-3014,852USD92
2017-03-01 to 2017-09-3047,564USD214
2016-07-01 to 2016-09-3075,198USD92
2016-03-01 to 2016-09-30147,136USD214

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-3037,930,620shares
At 2017-02-2837,821,198shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-09-302,354,252USD
At 2017-02-282,251,232USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-09-301,452,177USD
At 2017-02-281,319,140USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2017-09-3031,583USD
At 2017-02-2831,490USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-09-30502,249USD
At 2017-02-28417,357USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-07-01 to 2017-09-3077,517USD92
2017-03-01 to 2017-09-30179,874USD214
2016-07-01 to 2016-09-3070,935USD92
2016-03-01 to 2016-09-30167,513USD214

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-07-01 to 2017-09-30361USD92
2017-03-01 to 2017-09-301,104USD214
2016-07-01 to 2016-09-30262USD92
2016-03-01 to 2016-09-301,336USD214

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-07-01 to 2017-09-3010,780USD92
2017-03-01 to 2017-09-3066,183USD214
2016-07-01 to 2016-09-30-3,834USD92
2016-03-01 to 2016-09-309,573USD214

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-03-01 to 2017-09-3038,321USD214
2016-03-01 to 2016-09-30293,821USD214

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-03-01 to 2017-09-30232,865USD214
2016-03-01 to 2016-09-3071,011USD214

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-03-01 to 2017-09-30-409,550USD214
2016-03-01 to 2016-09-30357,384USD214

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
2026-09-19T14:58:00.731Z
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))